BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 12094263)

  • 1. T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis.
    van der Velden VH; Wijkhuijs JM; Jacobs DC; van Wering ER; van Dongen JJ
    Leukemia; 2002 Jul; 16(7):1372-80. PubMed ID: 12094263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR.
    van der Velden VH; Willemse MJ; van der Schoot CE; Hählen K; van Wering ER; van Dongen JJ
    Leukemia; 2002 May; 16(5):928-36. PubMed ID: 11986956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal residual disease monitoring in adult T-cell acute lymphoblastic leukemia: a molecular based approach using T-cell receptor G and D gene rearrangements.
    Gameiro P; Mortuza FY; Hoffbrand AV; Foroni L
    Haematologica; 2002 Nov; 87(11):1126-34. PubMed ID: 12414341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia.
    Brüggemann M; van der Velden VH; Raff T; Droese J; Ritgen M; Pott C; Wijkhuijs AJ; Gökbuget N; Hoelzer D; van Wering ER; van Dongen JJ; Kneba M
    Leukemia; 2004 Apr; 18(4):709-19. PubMed ID: 14961040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related patterns of immunoglobulin and T-cell receptor gene rearrangements in precursor-B-ALL: implications for detection of minimal residual disease.
    van der Velden VH; Szczepanski T; Wijkhuijs JM; Hart PG; Hoogeveen PG; Hop WC; van Wering ER; van Dongen JJ
    Leukemia; 2003 Sep; 17(9):1834-44. PubMed ID: 12970784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes.
    Pongers-Willemse MJ; Verhagen OJ; Tibbe GJ; Wijkhuijs AJ; de Haas V; Roovers E; van der Schoot CE; van Dongen JJ
    Leukemia; 1998 Dec; 12(12):2006-14. PubMed ID: 9844931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rearrangements of IgH, TCRD and TCRG genes as clonality marker of childhood acute lymphoblastic leukemia.
    Meleshko AN; Lipay NV; Stasevich IV; Potapnev MP
    Exp Oncol; 2005 Dec; 27(4):319-24. PubMed ID: 16404354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.
    van der Velden VH; Hochhaus A; Cazzaniga G; Szczepanski T; Gabert J; van Dongen JJ
    Leukemia; 2003 Jun; 17(6):1013-34. PubMed ID: 12764363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell receptor gamma and delta gene rearrangements and junctional region characteristics in south Indian patients with T-cell acute lymphoblastic leukemia.
    Sudhakar N; Nancy NK; Rajalekshmy KR; Ramanan G; Rajkumar T
    Am J Hematol; 2007 Mar; 82(3):215-21. PubMed ID: 17133429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonality profile in relapsed precursor-B-ALL children by GeneScan and sequencing analyses. Consequences on minimal residual disease monitoring.
    Germano G; del Giudice L; Palatron S; Giarin E; Cazzaniga G; Biondi A; Basso G
    Leukemia; 2003 Aug; 17(8):1573-82. PubMed ID: 12886245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology.
    Nakao M; Janssen JW; Flohr T; Bartram CR
    Cancer Res; 2000 Jun; 60(12):3281-9. PubMed ID: 10866322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Identification of immunoglobulin and T-cell receptor gene rearrangements--prerequisite for monitoring of minimal residual disease in Polish acute lymphoblastic leukemia patients based on European standards. Preliminary results].
    Dawidowska M; Derwich K; Szczepański T; Jółkowska J; Witt M; Wachowiak J
    Med Wieku Rozwoj; 2006; 10(1 Pt 2):323-34. PubMed ID: 17028396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease.
    Szczepański T; Beishuizen A; Pongers-Willemse MJ; Hählen K; Van Wering ER; Wijkhuijs AJ; Tibbe GJ; De Bruijn MA; Van Dongen JJ
    Leukemia; 1999 Feb; 13(2):196-205. PubMed ID: 10025893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid detection of gammaT cell receptor gene rearrangements in acute lymphoblastic leukemia by electrophoresis and silver staining: implications for detection of minimal residual disease.
    Valetto A; Lanciotti M; Di Martino D; Anselmi G; Bottini F; Mori P; Candiano G
    Electrophoresis; 1998 Jun; 19(8-9):1385-7. PubMed ID: 9694286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia.
    Verhagen OJ; Willemse MJ; Breunis WB; Wijkhuijs AJ; Jacobs DC; Joosten SA; van Wering ER; van Dongen JJ; van der Schoot CE
    Leukemia; 2000 Aug; 14(8):1426-35. PubMed ID: 10942239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL.
    van der Velden VH; Jacobs DC; Wijkhuijs AJ; Comans-Bitter WM; Willemse MJ; Hählen K; Kamps WA; van Wering ER; van Dongen JJ
    Leukemia; 2002 Aug; 16(8):1432-6. PubMed ID: 12145681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRD detection in acute lymphoblastic leukemia patients using Ig/TCR gene rearrangements as targets for real-time quantitative PCR.
    van der Velden VH; van Dongen JJ
    Methods Mol Biol; 2009; 538():115-50. PubMed ID: 19277574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of non-concordance in the T-cell receptor gamma chain genes at presentation and clinical relapse in acute lymphoblastic leukemia.
    Taylor JJ; Rowe D; Kylefjord H; Chessells J; Katz F; Proctor SJ; Middleton PG
    Leukemia; 1994 Jan; 8(1):60-6. PubMed ID: 8289500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of minimal residual disease in childhood acute lymphoblastic leukemia: comparison between RQ-PCR analysis of Ig/TcR gene rearrangements and multicolor flow cytometric immunophenotyping.
    Malec M; van der Velden VH; Björklund E; Wijkhuijs JM; Söderhäll S; Mazur J; Björkholm M; Porwit-MacDonald A
    Leukemia; 2004 Oct; 18(10):1630-6. PubMed ID: 15295608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of clonal immunoglobulin and T-cell receptor gene rearrangements in newly diagnosed adult patients with acute lymphoblastic leukemia by using multiplex PCR protocols].
    Yao L; Chen ZX; Cen JN; Liang JY; He J; Qi XF; Shen HJ
    Zhonghua Xue Ye Xue Za Zhi; 2008 Oct; 29(10):676-8. PubMed ID: 19176062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.